{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T18:12:03Z","timestamp":1767204723130,"version":"build-2238731810"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T00:00:00Z","timestamp":1666569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019065","name":"Tianjin Science and Technology Program","doi-asserted-by":"publisher","award":["Grant No.18YFZCSY00110"],"award-info":[{"award-number":["Grant No.18YFZCSY00110"]}],"id":[{"id":"10.13039\/501100019065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Heart failure (HF), the final stage of cardiovascular diseases, is a clinical syndrome of cardiac structural or functional abnormalities. QiShenYiQi Dripping Pills, short for QSYQ, showed effectiveness and safety in the treatment of HF according to modern pharmacological research and clinical studies, but the mechanism remains unclear. This study aims to clarify the mechanism of QSYQ in treating heart failure through the analysis to critical biomarkers, targets and pathways.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Materials and Methods:<\/jats:bold>\n                    In this study, the efficacies of QSYQ in non-human primates and rodents were evaluated, and the mechanism was demonstrated by integrating network pharmacology and metabolomics analysis. Furthermore, the targets from network pharmacology and the metabolites from targeted metabolomics were jointly analyzed to screen the critical pathways.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    In rhesus monkeys with spontaneous chronic heart failure, nasogastric administration of QSYQ for 12\u00a0weeks caused profound improvement of systolic and diastolic function as evidenced by echocardiography detection. Consistently, QSYQ administration especially with higher dose lowered the blood pressure and improved the ventricular remodeling, collagen deposition and fibrosis markedly in Spontaneous Hypertension Rats (SHR) model. Computational prediction showed that QSYQ exhibited anti-HF effects possibly through HIF-1 signaling pathway, FoxO signaling pathway, TNF signaling pathway, PI3K-Akt signaling pathway and other enriched paths. Metabolomics analysis obtained 23 significantly altered metabolites, revealing that QSYQ significantly regulated the abnormal levels of fatty acids, carnitines, organic acids pyridines, nucleosides, which were mostly involved in myocardial energy metabolism related pathways.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    Based on serum and myocardium metabolomics and network pharmacology, the present study revealed that the actions of QSYQ in treating HF depend on multi-components, multi-targets and multi-pathways.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2022.1017433","type":"journal-article","created":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T05:00:51Z","timestamp":1666587651000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills against cardiac structural and functional abnormalities"],"prefix":"10.3389","volume":"13","author":[{"given":"Jun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zunyuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Rong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e13906","DOI":"10.1097\/MD.0000000000013906","article-title":"Qishenyiqi dripping pill improves ventricular remodeling and function in patients with chronic heart failure: A pooled analysis","volume":"98","author":"Chang","year":"2019","journal-title":"Med. Baltim."},{"key":"B2","doi-asserted-by":"publisher","first-page":"6612653","DOI":"10.1155\/2021\/6612653","article-title":"Clinical efficacy and safety of qishen yiqi dropping pill combined with conventional western medicine in the treatment of chronic heart failure: A systematic review and meta-analysis","volume":"2021","author":"Chen","year":"2021","journal-title":"Evid. Based. Complement. Altern. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cmet.2020.12.003","article-title":"The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure","volume":"33","author":"Cluntun","year":"2021","journal-title":"Cell. Metab."},{"key":"B4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.hfc.2019.09.001","article-title":"Hypertension and heart failure: Prevention, targets, and treatment","volume":"16","author":"Di Palo","year":"2020","journal-title":"Heart fail. Clin."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/s41418-020-00729-0","article-title":"Heart failure-emerging roles for the mitochondrial pyruvate carrier","volume":"28","author":"Fernandez-Caggiano","year":"2021","journal-title":"Cell. Death Differ."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/s42255-020-00276-5","article-title":"Mitochondrial pyruvate carrier abundance mediates pathological cardiac hypertrophy","volume":"2","author":"Fernandez-Caggiano","year":"2020","journal-title":"Nat. Metab."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e24285","DOI":"10.1097\/MD.0000000000024285","article-title":"Efficacy and safety of qishen yiqi dripping pills as a complementary treatment for heart failure: A protocol of updated systematic review and meta-analysis","volume":"100","author":"Guan","year":"2021","journal-title":"Med. Baltim."},{"key":"B8","doi-asserted-by":"publisher","first-page":"D514","DOI":"10.1093\/nar\/gki033","article-title":"Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders","volume":"33","author":"Hamosh","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/cvr\/cvs014","article-title":"Unfavourable consequences of chronic cardiac HIF-1\u03b1 stabilization","volume":"94","author":"Holscher","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"D1121","DOI":"10.1093\/nar\/gkx1076","article-title":"Therapeutic target database update 2018: Enriched resource for facilitating bench-to-clinic research of targeted therapeutics","volume":"46","author":"Hong","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang da","year":"2009","journal-title":"Nat. Protoc."},{"key":"B12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1253\/circj.CJ-17-1184","article-title":"Metabolomic analysis in heart failure","volume":"82","author":"Ikegami","year":"2017","journal-title":"Circ. J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/cvr\/cvn301","article-title":"Energy metabolism in heart failure and remodelling","volume":"81","author":"Ingwall","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"D833","DOI":"10.1093\/nar\/gkw943","article-title":"DisGeNET: A comprehensive platform integrating information on human disease-associated genes and variants","volume":"45","author":"Janet","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.bbamcr.2011.01.015","article-title":"Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart","volume":"1813","author":"Jaswal","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/mnfr.201501019","article-title":"N-methylnicotinamide protects against endothelial dysfunction and attenuates atherogenesis in apolipoprotein E-deficient mice","volume":"60","author":"Jiang","year":"2016","journal-title":"Mol. Nutr. Food Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"8620186","DOI":"10.1155\/2020\/8620186","article-title":"Efficacy and safety of oral Chinese patent medicine combined with conventional therapy for heart failure: An overview of systematic reviews","volume":"2020","author":"Lin","year":"2020","journal-title":"Evid. Based. Complement. Altern. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cmet.2019.11.001","article-title":"Gut microbiome fermentation determines the efficacy of exercise for diabetes prevention","volume":"31","author":"Liu","year":"2020","journal-title":"Cell. Metab."},{"key":"B19","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3892\/etm.2018.6957","article-title":"Protective effect of Qishen Yiqi dropping pills on the myocardium of rats with chronic heart failure","volume":"17","author":"Lu","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11655-019-3064-0","article-title":"Network pharmacology in research of Chinese medicine formula: Methodology, application and prospective","volume":"26","author":"Luo","year":"2020","journal-title":"Chin. J. Integr. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/s0735-1097(97)00344-6","article-title":"Doppler tissue imaging: A noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures","volume":"30","author":"Nagueh","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1758-2946-6-13","article-title":"Tcmsp: A database of systems pharmacology for drug discovery from herbal medicines","volume":"6","author":"Ru","year":"2014","journal-title":"J. Cheminform."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e3941","DOI":"10.1002\/bmc.3941","article-title":"Simultaneous determination of eight bioactive components of Qishen Yiqi dripping pills in rat plasma using UFLC-MS\/MS and its application to a pharmacokinetic study","volume":"31","author":"Shao","year":"2017","journal-title":"Biomed. Chromatogr."},{"key":"B24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1758-2946-4-31","article-title":"Drug-likeness analysis of traditional Chinese medicines: 1. Property distributions of drug-like compounds, non-drug-like compounds and natural compounds from traditional Chinese medicines","volume":"4","author":"Shen","year":"2012","journal-title":"J. Cheminform."},{"key":"B25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","article-title":"Physiological and pathological cardiac hypertrophy","volume":"97","author":"Shimizu","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.hfc.2019.06.005","article-title":"The evolution from hypertension to heart failure","volume":"15","author":"Sorrentino","year":"2019","journal-title":"Heart fail. Clin."},{"key":"B27","doi-asserted-by":"publisher","first-page":"7279361","DOI":"10.1155\/2016\/7279361","article-title":"Synergism of Chinese herbal medicine: Illustrated by danshen compound","volume":"2016","author":"Su","year":"2016","journal-title":"Evid. Based. Complement. Altern. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/cphy.c140055","article-title":"Pathophysiology of heart failure","volume":"6","author":"Tanai","year":"2015","journal-title":"Compr. Physiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s00204-015-1477-x","article-title":"Pathophysiology of cardiac hypertrophy and heart failure: Signaling pathways and novel therapeutic targets","volume":"89","author":"Tham","year":"2015","journal-title":"Arch. Toxicol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/clpt.2012.96","article-title":"Pharmacogenomics knowledge for personalized medicine","volume":"92","author":"Whirl\u2010Carrillo","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: A major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1161\/ATVBAHA.114.303817","article-title":"Increased plasma S-adenosylhomocysteine-accelerated atherosclerosis is associated with epigenetic regulation of endoplasmic reticulum stress in apoE-\/- mice","volume":"35","author":"Xiao","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.arr.2017.11.002","article-title":"FOXO1\/3: Potential suppressors of fibrosis","volume":"41","author":"Xin","year":"2018","journal-title":"Ageing Res. Rev."},{"key":"B34","doi-asserted-by":"publisher","first-page":"6964","DOI":"10.3390\/ijms13066964","article-title":"A novel chemometric method for the prediction of human oral bioavailability","volume":"13","author":"Xu","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/s1875-5364(15)30078-9","article-title":"Therapeutic effects of Qishen Yiqi Dropping Pill on myocardial injury induced by chronic hypoxia in rats","volume":"13","author":"Yu","year":"2015","journal-title":"Chin. J. Nat. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jpba.2007.12.037","article-title":"Identification of major constituents in the traditional Chinese medicine \"QI-SHEN-YI-QI\" dropping pill by high-performance liquid chromatography coupled with diode array detection-electrospray ionization tandem mass spectrometry","volume":"47","author":"Yunfei","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"key":"B37","doi-asserted-by":"publisher","first-page":"6393","DOI":"10.1111\/jcmm.14527","article-title":"Qishen Yiqi Drop Pill, a novel compound Chinese traditional medicine protects against high glucose-induced injury in cardiomyocytes","volume":"23","author":"Zhang","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"510","DOI":"10.2174\/1389200211209050510","article-title":"Metabolite profiling and pharmacokinetics of herbal compounds following oral administration of a cardiovascular multi-herb medicine (Qishen yiqi pills) in rats","volume":"13","author":"Zhang","year":"2012","journal-title":"Curr. Drug Metab."},{"key":"B39","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2174\/1874467214666210811153610","article-title":"The therapeutic effect and mechanism of Qishen Yiqi dripping pills on cardiovascular and cerebrovascular diseases and diabetic complications","volume":"15","author":"Zhao","year":"2021","journal-title":"Curr. Mol. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"497314","DOI":"10.1155\/2015\/497314","article-title":"The mechanism research of qishen yiqi formula by module-network analysis","volume":"2015","author":"Zheng","year":"2015","journal-title":"Evid. Based. Complement. Altern. Med."}],"updated-by":[{"DOI":"10.3389\/fphar.2022.1080645","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000}}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1017433\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T11:52:47Z","timestamp":1669722767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1017433\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,24]]},"references-count":40,"alternative-id":["10.3389\/fphar.2022.1017433"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.1017433","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,24]]},"article-number":"1017433"}}